07:41
Using Artificial Intelligence Algorithms to Predict Seizure Control Following Brain Surgery
08:48
Exploring Gaps in RLS Treatment Through New 2024 Guidelines
04:16
Assessing Omaveloxoloneâs Positive Long-Term Safety Profile
23:37
Episode 130: The Promise Behind Cell Therapy Approaches in Epilepsy
02:55
Assessing Phase 2 Data on Bepranemabâs Effect on Tau Accumulation and Cognitive Function video
05:11
Acumen Pharmaceuticalsâ Phase 2 Advancements in Alzheimer Disease Screening
05:22
Highlights on Exploring Advances in Headache Medicine from AHS Scottsdale 2024
24:26
Episode 129: Implications of the 2024 AASM Guidelines for Restless Legs Syndrome
06:27
Advancing Alzheimer Treatment Through Gamma Oscillation Stimulation
05:27
Evolution of Multiple Sclerosis Diagnostic Criteria and the Role of Spinal Taps
05:23
Driving Innovation in Aging and Neurodegenerative Research
06:55
Guidance on Safe Use of Donanemab for Alzheimer Disease in Clinical Settings
06:43
Clinical Validation and Real World Impact of PrecivityAD2 Test for Alzheimer Diagnosis
05:00
Early Clinical Use of Anti Amyloid Therapy for Alzheimer Disease in Japan
04:25
Predicting Response to Cannabinoid Treatment for Agitation in Alzheimer Disease
21:13
Episode 128: Machine Learning Algorithms to Predict Seizure Control in Epilepsy Surgery
03:50
Marking a New Era in Patient Care With Advancements in Disease Modifying Alzheimer Treatments
05:37
Enhancing Diversity and Accessibility in Clinical Trials for Alzheimer Disease
08:27
New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists
15:03
Episode 127: Adapting Neuromuscular and Electrodiagnostic Medicine Education for Modern Learners
07:28
Understanding the Approval of Once Nightly Sodium Oxybate for Pediatric Narcolepsy
06:32
Highlighting More Risk Factors and Treatments in Updated Stroke Prevention Guidelines
05:36
Therapeutic Potential of Combination Strategies to Treat Alzheimer Disease
12:23
Special Episode: FDA Approves Sodium Oxybate for Pediatric Narcolepsy
06:38
Overviewing Cleveland Clinicâs International Epilepsy Summit
03:50
Cultural Shifts in Adapting to the New Criteria for Multiple Sclerosis Diagnosis
14:25
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
04:03
Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision
03:42
Sex Based Genetic Risk and Immune Response Differences in Alzheimer Disease
09:01
Medicare Part D 2025 Key Changes and Payment Plan for Multiple Sclerosis
03:37
A Clinical Approach to Recognizing and Diagnosing Restless Leg Syndrome
04:23
Promising Effects of Vidofludimus Calcium by Age and Disability in Progressive MS
03:57
Understanding Radiologically Isolated Syndrome as Presymptomatic MS or an Independent Condition
27:03
Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis
05:06
Using the DAAE Score to Advance Personalized Medicine for Multiple Sclerosis
03:07
Perspectives on Updated McDonald Criteria to Transform MS Diagnosis
05:12
A Melting Pot of Strategies and Collaboration at the 2025 MDA Conference
02:28
The Promising Results of Tolebrutinib for Secondary Progressive MS Treatment
03:41
Factors Influencing Time Delays in Initiating High Efficacy Treatment in Multiple Sclerosis
04:11
Comparative Analysis Insights on Neuromyelitis Optica Spectrum Disorder Treatments
19:47
Episode 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy
04:38
Understanding Smoldering Disease in MS Beyond Focal Inflammatory Activity
07:47
Proof of Concept Behind Neuroprotective Agent NA-831 and Lecanemab for Alzheimer Disease
08:35
Overviewing Encouraging Early-Stage Data on Mivelsiran, RNA Therapeutic for Alzheimer Disease
05:18
Promise and Potential Challenges With Gene Therapy in Epilepsy
04:44
Therapeutic Potential of BTK Inhibitor Tolebrutinib in NonRelapsing Secondary Progressive MS
04:09
Raising Awareness for Spinal Muscular Atrophy and Improving Newborn Screening
05:02
The Need for Flexibility and Patient Centered Approaches in Clinical Trials for Cervical Dystonia
22:46
Episode 123: Previewing Cleveland Clinic's Epilepsy Summit
05:59
Exploring Cognitive Motor Dissociation in Consciousness Disorders
05:17
Development of a Tool to Enhance Diagnostics for Traumatic Brain Injury
03:15
Promising Diagnostic Approaches Emerging for Brain Pathologies
10:08
Exploring Genetic Variants and Global Challenges in Alzheimer Disease Research
24:30
Episode 122: RNA Therapeutics, Mivelsiran, and Treating Alzheimer Disease
08:33
Development of the DAAE Score for Predicting Progression in Multiple Sclerosis
05:22
Holistic Care and Advanced Technology Integration for Neurologic Disease Management
08:27
Recent Advancements in Alzheimer Disease Research Presented at AAIC 2024
03:49
Challenges in Early Diagnosis of Frontotemporal Dementia in Clinical Settings
05:20
Potential Cognitive Benefits of Using GLP-1 Analogs for Alzheimer Disease Treatment
06:55
Improving Alzheimer Disease Diagnosis Through Efficient Referrals of Blood Tests
X
About
NeurologyLive is a trusted news source for breaking drug approvals, pipeline trials, and emerging trends in neurology for physicians and clinicians. Visit neurologylive.com for more!
The multimedia publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information, and other resources that can help them provide better care to patients. At NeurologyLive, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts, and other multimedia resources.
Tags